Muntañola, A.
Baumann, T.
Caballero, A. C.
Sánchez-González, B.
Mercadal, S.
Escoda, L.
Soler, A.
Iserte, L.
Canet, M.
Villalobos, M. T.
Magnano, L.
Sorigué, M.
García, O.
Salar, A.
López-Guillermo, A.
Sancho, J. M.
Article History
Received: 14 February 2020
Accepted: 19 May 2020
First Online: 25 May 2020
Compliance with ethical standards
:
: AM has received a speaker honorarium and travel grants from Roche, Abbvie and Janssen and has participated in advisory boards for Roche, Abbvie and Janssen. TB has received lecture fees from Janssen, Abbvie and Gilead/Kite and has participated in advisory boards for Janssen. BSG reports none institutional research funding and is a consultant and/or speaker bureau for Novartis, Amgen, Takeda, Alexion, Gilead and Shire. SM has received lecture fees and travel grants from Roche. AS participated in a speaker’s bureau for Roche and Janssen, received travel grants from Roche, served on the advisory board of Celgene, Roche, Janssen and reports research funding from Roche and Gilead. ALG served on the advisory board of Roche, Celgene, Novartis, Gilead/Kite and received grants from Celgene, Gilead/Kite. JMS reports honoraria from Roche, Janssen, Gilead, Celgene, Novartis, Kern-pharma and Servier and has participated in advisory boards for Roche, Janssen, Gilead, Celgene, Novartis, Kern- Pharma and Celltrion. The remaining authors (ACC, LI, LE, JAS, MC, MTV, LM, OG and MS) have no conflict of interest.
: All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participant who was alive at the moment of the study onset.